Author: GlobeNewswire

EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to…

SAN FRANCISCO, July 21, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,…

Daix (France), Long Island City (New York, United States), July 21, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…

H1 2022 sales Slight business growth €371.1 M, up 2.2% from 1st half of 2021(-1.3% at constant exchange rates)Strong sales in…

London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) — Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an…

Announces $35 Million Above Market FinancingBolsters Company’s Position with Ongoing Strategic Discussions BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) —…

London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) — Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an…

CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June…